Suppr超能文献

[联合肝脏分隔和门静脉结扎分期肝切除术(ALPPS)——结直肠癌肝转移患者二期肝切除的新机遇]

[Associated liver partition and portal vein ligation for staged hepatectomy (ALPPS) - new opportunity in two-stage liver resection in patients with colorectal cancer metastases].

作者信息

Skipenko O G, Chardarov N K, Bagmet N N, Bedzhanian A L, Polishchuk L O, Shatverian G A

出版信息

Khirurgiia (Mosk). 2014(9):23-9.

Abstract

Major hepatic resection is often necessary for cure in patients with multiple colorectal cancer metastases but low future liver remnant (FLR) volume makes surgery risky because of the posthepatectomy liver failure (PHLF). Right portal vein ligation/embolization and two-stage hepatectomy were proposed previously to overcome this problem. Associated liver partition and portal vein ligation for staged hepatectomy (ALPPS) is a novel approach aimed for FLR volume hypertrophy. During the first stage right portal vein is ligated followed by liver parenchyma in situ splitting. Right liver lobe removal is performed during the second stage when FLR hypertrophy becomes sufficient. Three patients with colorectal cancer liver metastases were scheduled for major hepatic resection. ALPPS was applied because of insufficient FLR volume. We observed FLR hypertrophy of 77, 90 and 70% after 7, 7 and 14 days waiting period. FLR/Total Liver Volume ratio increased from 22, 23 and 15% to 33, 35 and 32% respectively. The second stage was performed successfully in all patients. All patients are alive and they have not disease relapse after 17, 15 and 15 months after surgery. ALPPS is promising technique that allows rapid FLR hypertrophy and enables curative liver resections in initially unresectable patients. But it is necessary more data concerning ALPPS safety and long-term results.

摘要

对于患有多发性结直肠癌转移但未来肝剩余(FLR)体积较小的患者,为了实现治愈往往需要进行大范围肝切除,但由于肝切除术后肝衰竭(PHLF),FLR体积较小会使手术风险增加。此前曾提出右门静脉结扎/栓塞和两阶段肝切除术来解决这一问题。联合肝脏分隔和门静脉结扎分期肝切除术(ALPPS)是一种旨在使FLR体积增大的新方法。在第一阶段结扎右门静脉,随后进行肝脏实质原位劈离。当FLR增大到足够程度时,在第二阶段进行右肝叶切除。3例结直肠癌肝转移患者计划进行大范围肝切除。由于FLR体积不足而应用了ALPPS。在等待7天、7天和14天后,我们观察到FLR分别增大了77%、90%和70%。FLR/全肝体积比分别从22%、23%和15%增加到33%、35%和32%。所有患者均成功进行了第二阶段手术。所有患者均存活,术后17个月、15个月和15个月均未出现疾病复发。ALPPS是一种有前景的技术,它能使FLR迅速增大,并能在最初无法切除的患者中实现根治性肝切除。但需要更多关于ALPPS安全性和长期结果的数据。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验